Presentation TVT 2013 Best Clinical Practices for Transfemoral TAVR Presenter: Susheel Kodali June 12, 2013
Presentation TVT 2013 Baseline Frailty Status of the "Extreme Risk" Patients in the US CoreValve Trial Presenter: Jeffrey Popma June 12, 2013
Presentation TVT 2013 Are There Indications for Direct Surgical Femoral Artery Cutdown and Repair? Presenter: Olaf Wendler June 12, 2013
Presentation TVT 2013 Are Dedicated Transcutaneous LV Apical Access Closure Technologies Important to "Revive" the TA-TAVR Procedure? Presenter: Joerg Kempfert June 12, 2013
Presentation TVT 2013 An Artificial Construct Doomed to Extinction Presenter: Ganesh Manoharan June 12, 2013
Presentation TVT 2013 An Anticoagulated Patient with Severe Paravalvular Regurgitation and Ostial Left Main Disease Presenter: Peter Pollak June 12, 2013
Presentation TVT 2013 Access Screening for TAVR: Who Should and Shouldn't Be Transfemoral Candidates Presenter: Mathew Williams June 12, 2013
Presentation TVT 2013 A Whirlwind Tour of the New LV Apical Access Closure Devices: Focus on Technology Presenter: Thomas Walther June 12, 2013
Presentation TVT 2013 A Direct Flow Medical Transcatheter Aortic Valve Implantation Case: Repositioning to Optimize Result and Echo Assessment Prior to Final Implantation Presenter: Federico De Marco June 12, 2013
Presentation TVT 2012 Why Is Frailty Important? Insights from the US CoreValve TAVR Study(2) Presenter: Jeffrey Popma June 05, 2012
Presentation TVT 2012 Perspectives from the "Inoperable" Cohort of the US PARTNER Trial Presenter: Raj Makkar June 05, 2012
Presentation TVT 2012 Overview of Large Hole Transfemoral and Transapical Access-Closure Devices Presenter: Martin Leon June 05, 2012
Presentation TVT 2012 Case Screening Considerations: Who Should and Shouldn't Have Transfemoral TAVR(2) Presenter: Jean-Michel Paradis June 05, 2012